Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 7
1953 2
1954 1
2014 3
2015 2
2018 3
2019 4
2020 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients.
Kuemmel S, Heil J, Rueland A, Seiberling C, Harrach H, Schindowski D, Lubitz J, Hellerhoff K, Ankel C, Graßhoff ST, Deuschle P, Hanf V, Belke K, Dall P, Dorn J, Kaltenecker G, Kuehn T, Beckmann U, Potenberg J, Blohmer JU, Kostara A, Breit E, Holtschmidt J, Traut E, Reinisch M. Kuemmel S, et al. Among authors: holtschmidt j. Ann Surg. 2022 Nov 1;276(5):e553-e562. doi: 10.1097/SLA.0000000000004572. Epub 2020 Nov 4. Ann Surg. 2022. PMID: 33156057
Hematogenous dissemination of glioblastoma multiforme.
Müller C, Holtschmidt J, Auer M, Heitzer E, Lamszus K, Schulte A, Matschke J, Langer-Freitag S, Gasch C, Stoupiec M, Mauermann O, Peine S, Glatzel M, Speicher MR, Geigl JB, Westphal M, Pantel K, Riethdorf S. Müller C, et al. Among authors: holtschmidt j. Sci Transl Med. 2014 Jul 30;6(247):247ra101. doi: 10.1126/scitranslmed.3009095. Sci Transl Med. 2014. PMID: 25080476
Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone Receptor-Positive/ERBB2-Positive Early Breast Cancer: The Neoadjuvant WSG-TP-II Randomized Clinical Trial.
Gluz O, Nitz UA, Christgen M, Kuemmel S, Holtschmidt J, Schumacher J, Hartkopf A, Potenberg J, Lüedtke-Heckenkamp K, Just M, Schem C, von Schumann R, Kolberg-Liedtke C, Eulenburg CZ, Schinköthe T, Graeser M, Wuerstlein R, Kates RE, Kreipe HH, Harbeck N. Gluz O, et al. Among authors: holtschmidt j. JAMA Oncol. 2023 Jul 1;9(7):946-954. doi: 10.1001/jamaoncol.2023.0646. JAMA Oncol. 2023. PMID: 37166817 Clinical Trial.
[Sclerodermiform basaliomata].
HERZBERG JJ, HOLTSCHMIDT J. HERZBERG JJ, et al. Among authors: holtschmidt j. Hautarzt. 1952 Aug;3(8):371-2. Hautarzt. 1952. PMID: 12989743 Undetermined Language. No abstract available.
[Igelite dermatitis].
HOLTSCHMIDT J. HOLTSCHMIDT J. Hautarzt. 1952 May;3(5):227-8. Hautarzt. 1952. PMID: 14945745 Undetermined Language. No abstract available.
Reply to E. Hindié and A.K. Goel et al.
Holtschmidt J, Kuemmel S, Krug D, Breit E, Kuehn T, Reinisch M. Holtschmidt J, et al. J Clin Oncol. 2019 Oct 10;37(29):2705-2707. doi: 10.1200/JCO.19.01860. Epub 2019 Aug 29. J Clin Oncol. 2019. PMID: 31465263 No abstract available.
[Treatment of scleroderma].
HOLTSCHMIDT J. HOLTSCHMIDT J. Dtsch Med Wochenschr. 1953 Jun 5;78(23):853-4. doi: 10.1055/s-0028-1131380. Dtsch Med Wochenschr. 1953. PMID: 13068009 Undetermined Language. No abstract available.
Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) Trial.
Kuemmel S, Holtschmidt J, Gerber B, Von der Assen A, Heil J, Thill M, Krug D, Schem C, Denkert C, Lubitz J, Blohmer JU, Reinisch M, Hötzeldt M, Seither F, Nekljudova V, Schwidde I, Uhrhan K, Von Minckwitz G, Rezai M, Mulowski J, Loibl S, Kuehn T. Kuemmel S, et al. Among authors: holtschmidt j. J Clin Oncol. 2019 Jun 10;37(17):1490-1498. doi: 10.1200/JCO.18.02092. Epub 2019 May 1. J Clin Oncol. 2019. PMID: 31042410 Clinical Trial.
24 results